10 results on '"Mo, Wei"'
Search Results
2. A novel oncotherapy strategy: Direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non‐small cell lung cancer.
- Author
-
Zhao, Bing, Wu, Mengfang, Hu, Zhihuang, Wang, Tianfa, Yu, Jinchao, Ma, Yixin, Wang, Qi, Zhang, Yanling, Chen, Di, Li, Tianyu, Li, Yaran, Yu, Min, Wang, Huijie, and Mo, Wei
- Abstract
Background and Purpose: Cancer cachexia and cancer‐associated thrombosis are potentially fatal outcomes of advanced cancer. Nevertheless, thrombin expression in non‐small cell lung cancer (NSCLC) primary tumour tissues and the association between prognosis of NSCLC patients remain largely unknown. Experimental Approach Clinical pathological analysis was performed to determine the relationship between thrombin and tumour progression. Effects of r‐hirudin and direct thrombin inhibitor peptide (DTIP) on cancer progression were evaluated. Western blotting, immunohistochemistry, and immunofluorescence were used to explore the inhibition mechanism of r‐hirudin and DTIP. The therapeutic effect of the combination of DTIP and chemotherapy was determined. Key Results: Thrombin expression in NSCLC tissues was closely related to clinicopathological features and the prognosis of patients. Thrombin deficiency inhibited tumour progression. The novel thrombin inhibitors, r‐hirudin and DTIP, inhibited cell invasion and metastasis in vitro. They inhibited tumour growth and metastasis in orthotopic lung cancer model, inhibited cell invasion, and prolonged survival after injection of tumour cells via the tail vein. They also inhibited angiogenesis and spontaneous metastases from subcutaneously inoculated tumours. The promotion by thrombin of invasion and metastasis was abolished in PAR‐1‐deficient NSCLC cells. r‐hirudin and DTIP inhibited tumour progression through the thrombin‐PAR‐1‐mediated RhoA and NF‐κB signalling cascades via inhibiting MMP9 and IL6 expression. DTIP potentiated chemotherapy‐induced growth and metastatic inhibition and inhibited chemotherapy‐induced resistance in mice. Conclusions and Implications: Thrombin makes a substantial contribution, together with PAR‐1, to NSCLC malignancy. The anti‐coagulants, r‐hirudin and DTIP, could be used in anti‐tumour therapy and a combination of DTIP and chemotherapy might improve therapeutic effects. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Temporarily Epigenetic Repression in Bergmann Glia Regulates the Migration of Granule Cells.
- Author
-
Chen, Shaoxuan, Zhang, Kunkun, Zhang, Boxin, Jiang, Mengyun, Zhang, Xue, Guo, Yi, Yu, Yingying, Qin, Tianyu, Li, Hongda, Chen, Qiang, Cai, Zhiyu, Luo, Site, Huang, Yi, Hu, Jin, and Mo, Wei
- Subjects
GRANULE cells ,CELL migration ,PURKINJE cells ,EXTRACELLULAR matrix ,EPIGENETICS - Abstract
Forming tight interaction with both Purkinje and granule cells (GCs), Bergmann glia (BG) are essential for cerebellar morphogenesis and neuronal homeostasis. However, how BG act in this process is unclear without comprehensive transcriptome landscape of BG. Here, high temporal‐resolution investigation of transcriptomes with FACS‐sorted BG revealed the dynamic expression of genes within given functions and pathways enabled BG to assist neural migration and construct neuron‐glia network. It is found that the peak time of GCs migration (P7‐10) strikingly coincides with the downregulation of extracellular matrix (ECM) related genes, and the disruption of which by Setdb1 ablation at P7‐10 in BG leads to significant migration defect of GCs emphasizing the criticality of Nfix‐Setdb1 mediated H3K9me3 repressive complex for the precise regulation of GCs migration in vivo. Thus, BG's transcriptomic landscapes offer an insight into the mechanism by which BG are in depth integrated in cerebellar neural network. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
- Author
-
Pang, Yu‐Yan, Li, Jian‐Di, Gao, Li, Yang, Xia, Dang, Yi‐Wu, Lai, Ze‐Feng, Liu, Li‐Min, Yang, Jie, Wu, Hua‐Yu, He, Rong‐Quan, Huang, Zhi‐Guang, Xiong, Dan‐Dan, Yang, Li‐Hua, Shi, Lin, Mo, Wei‐Jia, Tang, Deng, Lu, Hui‐Ping, and Chen, Gang
- Subjects
IMMUNOSTAINING ,CHINESE medicine ,CHEMICAL carcinogenesis ,BIOMARKERS ,DOWNREGULATION ,HUMAN carcinogenesis - Abstract
Background: Hepatocellular carcinoma (HCC) remains one of the most common cancers worldwide and tends to be detected at an advanced stage. More effective biomarkers for HCC screening and prognosis assessment are needed and the mechanisms of HCC require further exploration. The role of MAOA in HCC has not been intensively investigated. Methods: In‐house tissue microarrays, genechips, and RNAsequencing datasets were integrated to explore the expression status and the clinical value of MAOA in HCC. Immunohistochemical staining was utilized to determine MAOA protein expression. Intersection genes of MAOA related co‐expressed genes and differentially expressed genes were obtained to perform functional enrichment analyses. In vivo experiment was conducted to study the impact of traditional Chinese medicine nitidine chloride (NC) on MAOA in HCC. Results: MAOA was downregulated and possessed an excellent discriminatory capability in HCC patients. Decreased MAOA correlated with poor prognosis in HCC patients. Downregulated MAOA protein was relevant to an advanced TNM stage in HCC patients. Co‐expressed genes that positively related to MAOA were clustered in chemical carcinogenesis, where CYP2E1 was identified as the hub gene. In vivo experiment showed that nitidine chloride significantly upregulated MAOA in a nude mouse HCC model. Conclusions: A decreased MAOA level is not only correlated with aggressive behaviors in males but also serves as a promising biomarker for the diagnosis and prognosis of HCC patients. Moreover, MAOA may play a role in AFB1 toxic transformation through its synergistic action with co‐expressed genes, especially CYP3A4. MAOA also serves as a potential therapy target of NC in HCC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Constituent diversity of ethanol extracts from pitaya.
- Author
-
Ma, Jinghua, Mo, Wei, Zhang, Pangpan, Lai, Yong, Li, Ximei, and Zhang, Dangquan
- Subjects
- *
ETHANOL , *DIETARY fiber , *EXTRACTS , *AMIDES , *ANTHOCYANINS , *ANALYTICAL chemistry - Abstract
Pitaya is rich in nutrition and unique in function and contains vegetable albumin, anthocyanins, rich vitamins, and water soluble dietary fiber, which are rare in fruits and vegetables. However, researches mostly focused on pitaya cultivation, biological characteristics, fresh‐keeping, and lacked analyses about chemical composition of pitaya. Therefore, ethanol extraction and GC/MS were used to extract and identify the bioactive components in pulp and pericarp of red pitaya and white pitaya. The extracting results showed that percentages of ethanol extracts from pulp and pericarp of red pitaya were 14.5% and 12%, whereas those of white pitaya were 16% and 12%. The GC/MS results showed that different kinds of bioactive constituents were identified in fresh pericarp and pulp of red pitaya and white pitaya. In the four ethanol extracts, there are rich polysiloxane plant organosilicon with total contents of 10.09%, 24.21%, 25.77%, and 23.25%. Meanwhile, there are many heterocyclic substances, and the content of pericarp is much higher than that of pulp. The four ethanol extracts also contain some other bioactive ingredients, such as esters, hydrocarbons, alcohols, amides, halides, and fatty acids, which can be used as raw materials for biomedicine, advanced cosmetics, and skin care products. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Downregulation of miRNA‐126‐3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
- Author
-
Chen, Shang‐Wei, Lu, Hui‐Ping, Chen, Gang, Yang, Jie, Huang, Wan‐Ying, Wang, Xiang‐Ming, Huang, Shu‐Ping, Gao, Li, Liu, Jun, Fu, Zong‐Wang, Chen, Peng, Zhai, Gao‐Qiang, Luo, Jiao, Li, Xiao‐Jiao, Huang, Zhi‐Guang, Li, Zu‐Yun, Gan, Ting‐Qing, Yang, Da‐Ping, Mo, Wei‐Jia, and Zhou, Hua‐Fu
- Subjects
SQUAMOUS cell carcinoma ,LUNGS ,GENE expression ,DOWNREGULATION ,BIOMARKERS - Abstract
Lung squamous cell carcinoma (LUSC) is the main pathological type of pulmonary malignant tumors; at present, less than 10% of patients with advanced metastatic LUSC live for more than 5 years. We previously reported that low expression of miRNA‐126‐3p is associated with the occurrence and progression of lung adenocarcinoma (LUAD). Here, we examined expression of miRNA‐126‐3p in 23 samples from patients with LUSCs and 23 normal control specimens by quantitative real‐time PCR (RT‐qPCR). Associations between miRNA‐126‐3p expression and clinical features were studied from materials derived from Gene Expression Omnibus (GEO) chips and The Cancer Genome Atlas (TCGA) database. Twelve online platforms were used to identify candidate target genes of miRNA‐126‐3p. Further analyses of the Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and protein–protein interaction (PPI) network were performed on the target genes. GEO microarray analysis, TCGA data mining, RT‐qPCR, and integration analysis consistently reported low expression of miRNA‐126‐3p in LUSC. A total of 42 genes were identified as potential target genes of miRNA‐126‐3p from online platforms, GEO microarrays, and the TCGA database. GO and KEGG analyses demonstrated that the target genes are involved in several biological processes that promote the progression of LUSC. SOX2, E2F2, and E2F3 were selected as hub genes from the PPI network for further analysis. In summary, our results suggest that the low expression of miRNA‐126‐3p may play a role in promoting the development of LUSC and miRNA‐126‐3p may be a biomarker for LUSC early diagnosis and prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Hypomagnetic fields cause anxiety in adult male mice.
- Author
-
Ding, Hai‐min, Wang, Xue, Mo, Wei‐chuan, Qin, Ling‐ling, Wong, Steven, Fu, Jing‐peng, Tan, Yan, Liu, Ying, He, Rong‐qiao, and Hua, Qian
- Published
- 2019
- Full Text
- View/download PDF
8. Characterization and high-yield production of non- N-glycosylated recombinant human BCMA-Fc in Pichia pastoris.
- Author
-
Hou, Weihua, Meng, Xianchao, Wang, Yuxiong, Mo, Wei, Wu, Yi, and Yu, Min
- Subjects
PICHIA pastoris ,B cells ,CELL proliferation ,CHIMERIC proteins ,IMMUNOLOGIC diseases ,PROMOTERS (Genetics) ,ANTIGEN analysis - Abstract
B-cell maturation antigen (BCMA) fused at the C-terminus to the Fc portion of human IgG1 (BCMA-Fc) blocks B-cell activating factor (BAFF) and proliferation-inducing ligand (APRIL)-mediated B-cell activation, leading to immune disorders. The fusion protein has been cloned and produced by several engineering cell lines. To reduce cost and enhance production, we attempted to express recombinant human BCMA-Fc (rhBCMA-Fc) in Pichia pastoris under the control of the AOX1 methanol-inducible promoter. To produce the target protein with uniform molecular weight and reduced immunogenicity, we mutated two predicted N-linked glycosylation sites. The secretory yield was improved by codon optimization of the target gene sequence. After fed-batch fermentation under optimized conditions, the highest yield (207 mg/L) of rhBCMA-Fc was obtained with high productivity (3.45 mg/L/h). The purified functional rhBCMA-Fc possessed high-binding affinity to APRIL and dose-dependent inhibition of APRIL-induced proliferative activity in vitro through three-step purification. Thus, this yeast-derived expression method could be a low-cost and effective alternative to the production of rhBCMA-Fc in mammalian cell lines. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. Decline of cell viability and mitochondrial activity in mouse skeletal muscle cell in a hypomagnetic field.
- Author
-
Fu, Jing‐Peng, Mo, Wei‐Chuan, Liu, Ying, and He, Rong‐Qiao
- Published
- 2016
- Full Text
- View/download PDF
10. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.
- Author
-
Ye, Jian, Ma, Chunling, Hsueh, Eddy C, Dou, Jie, Mo, Wei, Liu, Shuai, Han, Bing, Huang, Yi, Zhang, Yanping, Varvares, Mark A, Hoft, Daniel F, and Peng, Guangyong
- Abstract
Accumulating evidence suggests the immunosuppressive microenvironments created by malignant tumors represent a major obstacle for effective anti-tumor immunity. A better understanding of the suppressive mechanisms mediated by tumor microenvironments and the development of strategies to reverse the immune suppression are major challenges for the success of tumor immunotherapy. Here, we report that human tumor cells can induce senescence in naïve/effector T cells, exhibiting potent suppressive function in vitro and in vivo. We further show that tumor-derived endogenous cyclic adenosine monophosphate ( cAMP) is responsible for the induction of T-cell senescence. Importantly, activation of TLR8 signaling in tumor cells can block the induction and reverse the suppression of senescent naïve and tumor-specific T cells in vitro and in vivo, resulting in enhanced anti-tumor immunity. These studies identify a novel mechanism of human tumor-mediated immune suppression and provide a new strategy to reverse tumor immunosuppressive effects for tumor immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.